The United States will continue to press for a waiver of intellectual property rights for Covid-19 vaccines and treatments even as it and other Group of Seven rich nations sharply expand donations of vaccines to poorer countries.
If you are not happy with the results below please do another search
50 search results for:
The United States on June 10 raised the pressure on other Group of Seven (G7) leaders to share their vaccine hoards to bring an end to the pandemic by pledging to donate 500 million doses of the Pfizer coronavirus vaccine to the world’s poorest countries.
Britain agreed a partnership with the United States on Thursday to tackle new pandemics by bolstering disease surveillance and genomic sequencing worldwide, on the eve of a G7 leaders’ summit.
Ocugen had to change the Pennsylvania-based eye disease company’s application for the Covid-19 vaccine Covaxin from an Emergency Use Authorization to a full Biologics License Application (BLA) approval.
Across the pharmaceutical industry, forging collaborations are a key tool to bringing new medications through the clinic and to market. This week, multiple companies have partnered in attempts to bring forth new therapies. BioSpace took a look at some of these announcements.
Preliminary findings from two vaccine safety monitoring systems suggest a higher-than-expected number of cases of heart inflammation after the second dose of mRNA Covid-19 vaccines in young men, the U.S. Centers for Disease Control and Prevention (CDC) said on June 10.
Johnson & Johnson said on June 10 the U.S. Food and Drug Administration extended the shelf life of the company’s single-shot Covid-19 vaccine from three months to four-and-a-half months, as millions of unused doses nationwide near expiration.
McCann Health New York announced the promotion of General Manager Matt Silver to the role of President. His promotion was announced during a period of tremendous growth and industry recognition for the agency, domestically and on the global stage.
Med Ad News caught up with David Ormesher, CEO of closerlook, and Ross Toohey, chief commercialization officer of Fishawack Health, to talk about Fishawack’s acquisition of closerlook, what made the deal so attractive on both ends, and what the acquisition promises for clients.
Moderna Inc. filed for U.S. authorization to use the company’s Covid-19 vaccine in adolescents aged 12 through 17, potentially offering healthcare providers and pediatricians an easier-to-store shot ahead of the return-to-school season in the fall.